BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 27220728)

  • 1. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA‑34a/c function as tumor suppressors in Hep‑2 laryngeal carcinoma cells and may reduce GALNT7 expression.
    Li W; Ma H; Sun J
    Mol Med Rep; 2014 Apr; 9(4):1293-8. PubMed ID: 24482044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-375 exhibits a more effective tumor-suppressor function in laryngeal squamous carcinoma cells by regulating KLF4 expression compared with simple co-transfection of miR-375 and miR-206.
    Guo Y; An R; Zhao R; Sun Y; Liu M; Tian L
    Oncol Rep; 2016 Aug; 36(2):952-60. PubMed ID: 27279635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
    Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
    J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells.
    Yang B; Huang J; Liu H; Guo W; Li G
    Tumour Biol; 2016 Feb; 37(2):1771-9. PubMed ID: 26318298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma.
    Li P; Lin XJ; Yang Y; Yang AK; Di JM; Jiang QW; Huang JR; Yuan ML; Xing ZH; Wei MN; Li Y; Yuan XH; Shi Z; Liu H; Ye J
    Cell Death Dis; 2019 Dec; 10(12):916. PubMed ID: 31801947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
    Shan X; Wen W; Zhu D; Yan T; Cheng W; Huang Z; Zhang L; Zhang H; Wang T; Zhu W; Zhu Y; Zhu J
    PLoS One; 2017; 12(1):e0170298. PubMed ID: 28099468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-632 Promotes Laryngeal Carcinoma Cell Proliferation, Migration, and Invasion Through Negative Regulation of GSK3β.
    Zhou ZX; Zhang ZP; Tao ZZ; Tan TZ
    Oncol Res; 2020 Feb; 28(1):21-31. PubMed ID: 29562960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
    Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14.
    Jia LF; Wei SB; Mitchelson K; Gao Y; Zheng YF; Meng Z; Gan YH; Yu GY
    PLoS One; 2014; 9(9):e108435. PubMed ID: 25268950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.
    Wang J; Tian X; Han R; Zhang X; Wang X; Shen H; Xue L; Liu Y; Yan X; Shen J; Mannoor K; Deepak J; Donahue JM; Stass SA; Xing L; Jiang F
    Oncogene; 2014 Feb; 33(9):1181-9. PubMed ID: 23474761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2.
    Ma ZL; Hou PP; Li YL; Wang DT; Yuan TW; Wei JL; Zhao BT; Lou JT; Zhao XT; Jin Y; Jin YX
    Tumour Biol; 2015 Apr; 36(4):2481-90. PubMed ID: 25501507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT2, a direct target of miR-212-5p, suppresses the proliferation and metastasis of colorectal cancer cells.
    Du F; Li Z; Zhang G; Shaoyan S; Geng D; Tao Z; Qiu K; Liu S; Zhou Y; Zhang Y; Gu J; Wang G; Li L; Wu W
    J Cell Mol Med; 2020 Sep; 24(17):9985-9998. PubMed ID: 32697380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
    Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
    Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑195 suppresses cell proliferation, migration and invasion in epithelial ovarian carcinoma via inhibition of the CDC42/CCND1 pathway.
    Hao X; Jia Q; Yuan J; Shi X; Guo H; Gao J; Guo Y
    Int J Mol Med; 2020 Nov; 46(5):1862-1872. PubMed ID: 32901852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.